Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Langenbeck's Archives of Surgery
Erschienen in: Langenbeck's Archives of Surgery 5/2015

01.07.2015 | Review Article

Transplantable bioartificial pancreas devices: current status and future prospects

verfasst von: Barbara Ludwig, Stefan Ludwig

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Islet transplantation has become a valuable therapy for patients with diabetes mellitus type 1.However, only selected patients with exhausted insulin therapy characterized by instable metabolic control and repeated severe hypoglycemia are transplant candidates. This strict indication is mainly due to the requirement for lifelong immunosuppression and the critical shortage for donor organs. Therefore, numerous research activities address these issues in order to provide beta cell replacement therapy to a broader cohort of patients with diabetes.

Methods

The encapsulation of pancreatic islets within mainly alginate-based macro- or microcapsules withvarious physical configurations may allow protecting the islet graft without the need for immunosuppressive agents and moreover expanding the donor pool to animal tissue and novel insulin-producing cells. Despite major advances in encapsulation technology, a significant translation into clinical application is not evident. There are still issues that need to be resolved associated with graft oxygenation, immunprotection, inflammatory response, material biocompatibility, and transplantation site to list some of them.

Conclusion

The recent advances in xenotransplantation and particularly in the field of stem cell-derived beta cells have generated a renewed scientific interest in encapsulation. This review aims to provide an overview on current encapsulation technologies as a treatment modality in cell replacement therapy for type 1 diabetes.
Literatur
1.
Gruessner RW, Gruessner AC (2014) What defines success in pancreas and islet transplantation-insulin independence or prevention of hypoglycemia? A review. Transplant Proc 46(6):1898–1899PubMedCrossRef
2.
Maffi P, Secchi A (2015).Clinical results of islet transplantation. Pharmacol Res
3.
Balamurugan AN, Naziruddin B, Lockridge A, Tiwari M, Loganathan G, Takita M, Matsumoto S, Papas K, Trieger M, Rainis H, Kin T, Kay TW, Wease S, Messinger S, Ricordi C, Alejandro R, Markmann J, Kerr-Conti J, Rickels MR, Liu C, Zhang X, Witkowski P, Posselt A, Maffi P, Secchi A, Berney T, O’Connell PJ, Hering BJ, Barton FB (2014) Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999–2010. Am J Transplant 14(11):2595–2606PubMedCentralPubMedCrossRef
4.
Robertson RP (2015) Islet transplantation for type 1 diabetes, 2015: what have we learned from alloislet and autoislet successes? Diabetes Care 38(6):1030–1035PubMedCrossRef
5.
Matsumoto S, Takita M, Chaussabel D, Noguchi H, Shimoda M, Sugimoto K, Itoh T, Chujo D, SoRelle J, Onaca N, Naziruddin B, Levy MF (2011) Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-α. Cell Transplant 20(10):1641–1647PubMedCrossRef
6.
Fridell JA, Rogers J, Stratta RJ (2010) The pancreas allograft donor: current status, controversies, and challenges for the future. Clin Transpl 24(4):433–449CrossRef
7.
Stegall MD, Dean PG, Sung R, Guidinger MK, McBride MA, Sommers C, Basadonna G, Stock PG, Leichtman AB (2007) The rationale for the new deceased donor pancreas allocation schema. Transplantation 83(9):1156–1161PubMedCrossRef
8.
Nilsson B, Ekdahl KN, Korsgren O (2011) Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment. Curr Opin Organ Transplant 16(6):620–626PubMedCrossRef
9.
Krishnan R, Alexander M, Robles L, Foster CE 3rd, Lakey JR (2014) Islet and stem cell encapsulation for clinical transplantation. Rev Diabet Stud 11(1):84–101PubMedCentralPubMedCrossRef
10.
Scharp DW, Mason NS, Sparks RE (1984) Islet immuno-isolation: the use of hybrid artificial organs to prevent islet tissue rejection. World J Surg 8(2):221–229PubMedCrossRef
11.
Algire GH, Weaver JM, Prehn RT (1954) Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice. J Natl Cancer Inst 15(3):493–507PubMed
12.
Weaver JM, Algire GH, Prehn RT (1955) The growth of cells in vivo in diffusion chambers. II. The role of cells in the destruction of homografts in mice. J Natl Cancer Inst 15(6):1737–1767PubMed
13.
Algire GH, Weaver JM, Prehn RT (1957) Studies on tissue homotransplantation in mice, using diffusion-chamber methods. Ann N Y Acad Sci 64(5):1009–1013PubMedCrossRef
14.
Algire GH, Borders ML, Evans VJ (1958) Studies of heterografts in diffusion chambers in mice. J Natl Cancer Inst 20(6):1187–1201PubMed
15.
Algire GH (1957) Summary of studies of transplantation of homologous tissues. Fed Proc 16(2):601–602PubMed
16.
Algire GH (1957) Diffusion-chamber techniques for studies of cellular immunity. Ann N Y Acad Sci 69(4):663–667PubMedCrossRef
17.
Monaco AP, Maki T, Ozato H, Carretta M, Sullivan SJ, Borland KM, Mahoney MD, Chick WL, Muller TE, Wolfrum J et al (1991) Transplantation of islet allografts and xenografts in totally pancreatectomized diabetic dogs using the hybrid artificial pancreas. Ann Surg 214(3):339–360, discussion 361-332 PubMedCentralPubMedCrossRef
18.
Hymer WC, Wilbur DL, Page R, Hibbard E, Kelsey RC, Hatfield JM (1981) Pituitary hollow fiber units in vivo and in vitro. Neuroendocrinology 32(6):339–349PubMedCrossRef
19.
Zekorn T, Siebers U, Filip L, Mauer K, Schmitt U, Bretzel RG, Federlin K (1989) Bioartificial pancreas: the use of different hollow fibers as a diffusion chamber. Transplant Proc 21(1 Pt 3):2748–2750PubMed
20.
Maki T, Ubhi CS, Sanchez-Farpon H, Sullivan SJ, Borland K, Muller TE, Solomon BA, Chick WL, Monaco AP (1991) Successful treatment of diabetes with the biohybrid artificial pancreas in dogs. Transplantation 51(1):43–51PubMedCrossRef
21.
Maki T, Mullon CJ, Solomon BA, Monaco AP (1995) Novel delivery of pancreatic islet cells to treat insulin-dependent diabetes mellitus. Clin Pharmacokinet 28(6):471–482PubMedCrossRef
22.
Rafael E, Wernerson A, Arner P, Wu GS, Tibell A (1999) In vivo evaluation of glucose permeability of an immunoisolation device intended for islet transplantation: a novel application of the microdialysis technique. Cell Transplant 8(3):317–326PubMed
23.
Rafael E, Wernerson A, Arner P, Tibell A (1999) In vivo studies on insulin permeability of an immunoisolation device intended for islet transplantation using the microdialysis technique. Eur Surg Res 31(3):249–258PubMedCrossRef
24.
Scharp DW, Marchetti P (2014) Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution. Adv Drug Deliv Rev 67–68:35–73PubMedCrossRef
25.
de Groot M, Schuurs TA, van Schilfgaarde R (2004) Causes of limited survival of microencapsulated pancreatic islet grafts. J Surg Res 121(1):141–150PubMedCrossRef
26.
Barkai U, Weir GC, Colton CK, Ludwig B, Bornstein SR, Brendel MD, Neufeld T, Bremer C, Leon A, Evron Y, Yavriyants K, Azarov D, Zimermann B, Maimon S, Shabtay N, Balyura M, Rozenshtein T, Vardi P, Bloch K, de Vos P, Rotem A (2013) Enhanced oxygen supply improves islet viability in a new bioartificial pancreas. Cell Transplant 22(8):1463–1476PubMedCrossRef
27.
Ludwig B, Zimerman B, Steffen A, Yavriants K, Azarov D, Reichel A, Vardi P, German T, Shabtay N, Rotem A, Evron Y, Neufeld T, Mimon S, Ludwig S, Brendel MD, Bornstein SR, Barkai U (2010) A novel device for islet transplantation providing immune protection and oxygen supply. Horm Metab Res 42(13):918–922PubMedCrossRef
28.
Neufeld T, Ludwig B, Barkai U, Weir GC, Colton CK, Evron Y, Balyura M, Yavriyants K, Zimermann B, Azarov D, Maimon S, Shabtay N, Rozenshtein T, Lorber D, Steffen A, Willenz U, Bloch K, Vardi P, Taube R, de Vos P, Lewis EC, Bornstein SR, Rotem A (2013) The efficacy of an immunoisolating membrane system for islet xenotransplantation in minipigs. PLoS One 8(8):e70150PubMedCentralPubMedCrossRef
29.
Ludwig B, Rotem A, Schmid J, Weir GC, Colton CK, Brendel MD, Neufeld T, Block NL, Yavriyants K, Steffen A, Ludwig S, Chavakis T, Reichel A, Azarov D, Zimermann B, Maimon S, Balyura M, Rozenshtein T, Shabtay N, Vardi P, Bloch K, de Vos P, Schally AV, Bornstein SR, Barkai U (2012) Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc Natl Acad Sci U S A 109(13):5022–5027PubMedCentralPubMedCrossRef
30.
Ludwig B, Reichel A, Steffen A, Zimerman B, Schally AV, Block NL, Colton CK, Ludwig S, Kersting S, Bonifacio E, Solimena M, Gendler Z, Rotem A, Barkai U, Bornstein SR (2013) Transplantation of human islets without immunosuppression. Proc Natl Acad Sci U S A 110(47):19054–19058PubMedCentralPubMedCrossRef
31.
Lanza RP, Beyer AM, Staruk JE, Chick WL (1993) Biohybrid artificial pancreas. Long-term function of discordant islet xenografts in streptozotocin diabetic rats. Transplantation 56(5):1067–1072PubMedCrossRef
32.
Lanza RP, Borland KM, Lodge P, Carretta M, Sullivan SJ, Muller TE, Solomon BA, Maki T, Monaco AP, Chick WL (1992) Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 41(7):886–889PubMedCrossRef
33.
Lanza RP, Borland KM, Staruk JE, Appel MC, Solomon BA, Chick WL (1992) Transplantation of encapsulated canine islets into spontaneously diabetic BB/Wor rats without immunosuppression. Endocrinology 131(2):637–642PubMed
34.
Merani S, Toso C, Emamaullee J, Shapiro AM (2008) Optimal implantation site for pancreatic islet transplantation. Br J Surg 95(12):1449–1461PubMedCrossRef
35.
de Vos P, Spasojevic M, Faas MM (2010) Treatment of diabetes with encapsulated islets. Adv Exp Med Biol 670:38–53PubMedCrossRef
36.
Teramura Y, Iwata H (2010) Bioartificial pancreas microencapsulation and conformal coating of islet of Langerhans. Adv Drug Deliv Rev 62(7–8):827–840PubMedCrossRef
37.
Soon-Shiong P, Feldman E, Nelson R, Komtebedde J, Smidsrod O, Skjak-Braek G, Espevik T, Heintz R, Lee M (1992) Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 54(5):769–774PubMedCrossRef
38.
Lanza RP, Ecker DM, Kuhtreiber WM, Marsh JP, Ringeling J, Chick WL (1999) Transplantation of islets using microencapsulation: studies in diabetic rodents and dogs. J Mol Med (Berl) 77(1):206–210CrossRef
39.
40.
Calafiore R (1992) Transplantation of microencapsulated pancreatic human islets for therapy of diabetes mellitus. A preliminary report. Asaio J 38(1):34–37PubMedCrossRef
41.
Paredes Juarez GA, Spasojevic M, Faas MM, de Vos P (2014) Immunological and technical considerations in application of alginate-based microencapsulation systems. Front Bioeng Biotechnol 2:26PubMedCentralPubMedCrossRef
42.
Opara EC, McQuilling JP, Farney AC (2013) Microencapsulation of pancreatic islets for use in a bioartificial pancreas. Methods Mol Biol 1001:261–266PubMedCentralPubMedCrossRef
43.
Calafiore R, Basta G (2014) Clinical application of microencapsulated islets: actual prospectives on progress and challenges. Adv Drug Deliv Rev 67–68:84–92PubMedCrossRef
44.
De Vos P, Van Straaten JF, Nieuwenhuizen AG, de Groot M, Ploeg RJ, De Haan BJ, Van Schilfgaarde R (1999) Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes 48(7):1381–1388PubMedCrossRef
45.
Matsumoto S, Tan P, Baker J, Durbin K, Tomiya M, Azuma K, Doi M, Elliott RB (2014) Clinical porcine islet xenotransplantation under comprehensive regulation. Transplant Proc 46(6):1992–1995PubMedCrossRef
46.
Matsuda T, Kitamura T, Iwata H, Takano H, Akutsu T (1988) A hybrid artificial vascular graft based upon an organ reconstruction model. Significance and design criteria of an artificial basement membrane. ASAIO Trans 34(3):640–643PubMed
47.
Wang T, Lacik I, Brissova M, Anilkumar AV, Prokop A, Hunkeler D, Green R, Shahrokhi K, Powers AC (1997) An encapsulation system for the immunoisolation of pancreatic islets. Nat Biotechnol 15(4):358–362PubMedCrossRef
48.
Wang T, Adcock J, Kuhtreiber W, Qiang D, Salleng KJ, Trenary I, Williams P (2008) Successful allotransplantation of encapsulated islets in pancreatectomized canines for diabetic management without the use of immunosuppression. Transplantation 85(3):331–337PubMedCrossRef
49.
Drumheller PD, Elbert DL, Hubbell JA (1994) Multifunctional poly(ethylene glycol) semi-interpenetrating polymer networks as highly selective adhesive substrates for bioadhesive peptide grafting. Biotechnol Bioeng 43(8):772–780PubMedCrossRef
50.
Sawhney AS, Pathak CP, Hubbell JA (1993) Interfacial photopolymerization of poly(ethylene glycol)-based hydrogels upon alginate-poly(l-lysine) microcapsules for enhanced biocompatibility. Biomaterials 14(13):1008–1016PubMedCrossRef
51.
Sawhney AS, Pathak CP, Hubbell JA (1994) Modification of islet of langerhans surfaces with immunoprotective poly(ethylene glycol) coatings via interfacial photopolymerization. Biotechnol Bioeng 44(3):383–386PubMedCrossRef
52.
Hill RS, Cruise GM, Hager SR, Lamberti FV, Yu X, Garufis CL, Yu Y, Mundwiler KE, Cole JF, Hubbell JA, Hegre OD, Scharp DW (1997) Immunoisolation of adult porcine islets for the treatment of diabetes mellitus. The use of photopolymerizable polyethylene glycol in the conformal coating of mass-isolated porcine islets. Ann N Y Acad Sci 831:332–343PubMedCrossRef
53.
Cruise GM, Hegre OD, Lamberti FV, Hager SR, Hill R, Scharp DS, Hubbell JA (1999) In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant 8(3):293–306
54.
Tomei AA, Manzoli V, Fraker CA, Giraldo J, Velluto D, Najjar M, Pileggi A (2014) Device design and materials optimization of conformal coating for islets of Langerhans. Proc Natl Acad Sci U S A 111(29):10514–10519PubMedCentralPubMedCrossRef
55.
Wilson JT, Cui W, Chaikof EL (2008) Layer-by-layer assembly of a conformal nanothin PEG coating for intraportal islet transplantation. Nano Lett 8(7):1940–1948PubMedCentralPubMedCrossRef
56.
Gattas-Asfura KM, Stabler CL (2013) Bioorthogonal layer-by-layer encapsulation of pancreatic islets via hyperbranched polymers. ACS Appl Mater Interfaces 5(20):9964–9974PubMedCrossRef
57.
Teramura Y, Kaneda Y, Iwata H (2007) Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials 28(32):4818–4825PubMedCrossRef
58.
Rengifo HR, Giraldo JA, Labrada I, Stabler CL (2014) Long-term survival of allograft murine islets coated via covalently stabilized polymers. Adv Healthcare Mater 3(7):1061–1070CrossRef
59.
Zhi ZL, Kerby A, King AJ, Jones PM, Pickup JC (2012) Nano-scale encapsulation enhances allograft survival and function of islets transplanted in a mouse model of diabetes. Diabetologia 55(4):1081–1090PubMedCrossRef
60.
Ludwig B, Ludwig S, Steffen A, Saeger HD, Bornstein SR (2010) Islet versus pancreas transplantation in type 1 diabetes: competitive or complementary? Curr Diab Rep 10(6):506–511PubMedCrossRef
61.
van der Windt DJ, Echeverri GJ, Ijzermans JN, Cooper DK (2008) The choice of anatomical site for islet transplantation. Cell Transplant 17(9):1005–1014PubMedCrossRef
62.
van der Windt DJ, Bottino R, Casu A, Campanile N, Cooper DK (2007) Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 14(4):288–297PubMedCrossRef
63.
Robson SC, Cooper DK, d’Apice AJ (2000) Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 7(3):166–176PubMedCrossRef
64.
Kim JH, Oh BJ, Lee HN, Park HS, Park SG, Park KS (2011) Endothelial colony-forming cell coating of pig islets prevents xenogeneic instant blood-mediated inflammatory reaction. Cell Transplant 20(11-12):1805–1815PubMedCrossRef
65.
Hwang JW, Jung HS, Lee DY (2011) Inhibition of platelet adhesion onto intrahepatically transplanted islets using PEGylation for attenuating instant blood-mediated inflammatory reaction (IBMIR). J Control Release 152(Suppl 1):e213–e214PubMedCrossRef
66.
Teramura Y, Iwata H (2011) Improvement of graft survival by surface modification with poly(ethylene glycol)-lipid and urokinase in intraportal islet transplantation. Transplantation 91(3):271–278PubMedCrossRef
67.
Luan NM, Teramura Y, Iwata H (2011) Immobilization of soluble complement receptor 1 on islets. Biomaterials 32(20):4539–4545PubMedCrossRef
68.
Luan NM, Teramura Y, Iwata H (2011) Layer-by-layer co-immobilization of soluble complement receptor 1 and heparin on islets. Biomaterials 32(27):6487–6492PubMedCrossRef
69.
Chen H, Teramura Y, Iwata H (2011) Co-immobilization of urokinase and thrombomodulin on islet surfaces by poly(ethylene glycol)-conjugated phospholipid. J Control Release 150(2):229–234PubMedCrossRef
70.
Teramura Y, Iwata H (2009) Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation. Transplantation 88(5):624–630PubMedCrossRef
71.
Im BH, Jeong JH, Haque MR, Lee DY, Ahn CH, Kim JE, Byun Y (2013) The effects of 8-arm-PEG-catechol/heparin shielding system and immunosuppressive drug, FK506 on the survival of intraportally allotransplanted islets. Biomaterials 34(8):2098–2106PubMedCrossRef
72.
Hilbrands R, Huurman VA, Gillard P, Velthuis JH, De Waele M, Mathieu C, Kaufman L, Pipeleers-Marichal M, Ling Z, Movahedi B, Jacobs-Tulleneers-Thevissen D, Monbaliu D, Ysebaert D, Gorus FK, Roep BO, Pipeleers DG, Keymeulen B (2009) Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes 58(10):2267–2276PubMedCentralPubMedCrossRef
73.
74.
Calafiore R, Basta G, Luca G, Lemmi A, Racanicchi L, Mancuso F, Montanucci MP, Brunetti P (2006) Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant Proc 38(4):1156–1157PubMedCrossRef
75.
O’Sullivan ES, Vegas A, Anderson DG, Weir GC (2011) Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. Endocr Rev 32(6):827–844PubMedCentralPubMedCrossRef
76.
77.
Kirchhof N, Shibata S, Wijkstrom M, Kulick DM, Salerno CT, Clemmings SM, Heremans Y, Galili U, Sutherland DE, Dalmasso AP, Hering BJ (2004) Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 11(5):396–407PubMedCrossRef
78.
Soderlund J, Wennberg L, Castanos-Velez E, Biberfeld P, Zhu S, Tibell A, Groth CG, Korsgren O (1999) Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study. Transplantation 67(6):784–791PubMedCrossRef
79.
de Vos P, Marchetti P (2002) Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. Trends Mol Med 8(8):363–366PubMedCrossRef
80.
Klymiuk N, van Buerck L, Bahr A, Offers M, Kessler B, Wuensch A, Kurome M, Thormann M, Lochner K, Nagashima H, Herbach N, Wanke R, Seissler J, Wolf E (2012) Xenografted islet cell clusters from INSLEA29Y transgenic pigs rescue diabetes and prevent immune rejection in humanized mice. Diabetes 61(6):1527–1532PubMedCentralPubMedCrossRef
81.
Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49(11):1751–1760PubMedCrossRef
82.
Hellman B, Gylfe E, Bergsten P, Grapengiesser E, Lund PE, Berts A, Tengholm A, Pipeleers DG, Ling Z (1994) Glucose induces oscillatory Ca2+ signalling and insulin release in human pancreatic beta cells. Diabetologia 37(Suppl 2):S11–S20PubMedCrossRef
83.
Marchetti P, Scharp DW, McLear M, Gingerich R, Finke E, Olack B, Swanson C, Giannarelli R, Navalesi R, Lacy PE (1994) Pulsatile insulin secretion from isolated human pancreatic islets. Diabetes 43(6):827–830PubMedCrossRef
84.
Buchwald P, Cechin SR, Weaver JD, Stabler CL (2015) Experimental evaluation and computational modeling of the effects of encapsulation on the time-profile of glucose-stimulated insulin release of pancreatic islets. Biomed Eng Online 14(1):28PubMedCentralPubMedCrossRef
85.
Blasi P, Luca G, Mancuso F, Schoubben A, Calvitti M, Giovagnoli S, Basta G, Becchetti E, Ricci M, Calafiore R (2013) Conformal polymer coatings for pancreatic islets transplantation. Int J Pharm 440(2):141–147PubMedCrossRef
86.
Orive G, Hernandez RM, Gascon AR, Calafiore R, Chang TM, De Vos P, Hortelano G, Hunkeler D, Lacik I, Shapiro AM, Pedraz JL (2003) Cell encapsulation: promise and progress. Nat Med 9(1):104–107PubMedCrossRef
87.
Orive G, Gascon AR, Hernandez RM, Igartua M, Luis Pedraz J (2003) Cell microencapsulation technology for biomedical purposes: novel insights and challenges. Trends Pharmacol Sci 24(5):207–210PubMedCrossRef
88.
de Vos P, Hamel AF, Tatarkiewicz K (2002) Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 45(2):159–173PubMedCrossRef
89.
Vaithilingam V, Kollarikova G, Qi M, Lacik I, Oberholzer J, Guillemin GJ, Tuch BE (2011) Effect of prolonged gelling time on the intrinsic properties of barium alginate microcapsules and its biocompatibility. J Microencapsul 28(6):499–507PubMedCrossRef
90.
De Vos P, Vegter D, De Haan BJ, Strubbe JH, Bruggink JE, Van Schilfgaarde R (1996) Kinetics of intraperitoneally infused insulin in rats. Functional implications for the bioartificial pancreas. Diabetes 45(8):1102–1107PubMedCrossRef
91.
Yang HK,Yoon KH (2015) Current status of encapsulated islet transplantation. J Diabet Complications
92.
Pareta R, McQuilling JP, Sittadjody S, Jenkins R, Bowden S, Orlando G, Farney AC, Brey EM, Opara EC (2014) Long-term function of islets encapsulated in a redesigned alginate microcapsule construct in omentum pouches of immune-competent diabetic rats. Pancreas 43(4):605–613PubMedCentralPubMedCrossRef
93.
Juang JH, Bonner-Weir S, Ogawa Y, Vacanti JP, Weir GC (1996) Outcome of subcutaneous islet transplantation improved by polymer device. Transplantation 61(11):1557–1561PubMedCrossRef
94.
De Vos P, Hillebrands JL, De Haan BJ, Strubbe JH, Van Schilfgaarde R (1997) Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets. Transplantation 63(6):824–830PubMedCrossRef
95.
Eberhard D, Kragl M, Lammert E (2010) ‘Giving and taking’: endothelial and beta-cells in the islets of Langerhans. Trends Endocrinol Metab 21(8):457–463PubMedCrossRef
96.
Lammert E, Cleaver O, Melton D (2001) Induction of pancreatic differentiation by signals from blood vessels. Science 294(5542):564–567PubMedCrossRef
97.
Denner J,Graham M (2015) Xenotransplantation of islet cells: what can the non-human primate model bring for the evaluation of efficacy and safety? Xenotransplantation
98.
Graham ML, Bellin MD, Papas KK, Hering BJ, Schuurman HJ (2011) Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation. Xenotransplantation 18(6):328–342PubMedCrossRef
Metadaten
Titel
Transplantable bioartificial pancreas devices: current status and future prospects
verfasst von
Barbara Ludwig
Stefan Ludwig
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 5/2015
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-015-1314-y

Weitere Artikel der Ausgabe 5/2015

Langenbeck's Archives of Surgery 5/2015 Zur Ausgabe

Review Article

Donor liver histology—a valuable tool in graft selection

How-I-Do-It article

Endovascular stenting of mesenterico-portal vein stenosis to reduce blood flow through venous collaterals prior to pancreatoduodenectomy

Original Article

Hartmann’s procedure and laparoscopic reversal versus primary anastomosis and ileostomy closure for left colonic perforation

Original Article

Body mass index and ghrelin levels after laparoscopic Nissen fundoplication

Review Article

Cell therapy for immunosuppression after kidney transplantation

Original Article

Vitamin D level is not a predictor of hypocalcemia after total thyroidectomy

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.